These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 36877839

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Obscurin: A multitasking giant in the fight against cancer.
    Guardia T, Eason M, Kontrogianni-Konstantopoulos A.
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188567. PubMed ID: 34015411
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD.
    Luo D, Liang Y, Wang Y, Ye F, Jin Y, Li Y, Han D, Wang Z, Chen B, Zhao W, Wang L, Chen X, Jiang L, Yang Q.
    Breast Cancer Res; 2023 Sep 28; 25(1):109. PubMed ID: 37770991
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
    Mitobe Y, Ikeda K, Sato W, Kodama Y, Naito M, Gotoh N, Miyata K, Kataoka K, Sasaki H, Horie-Inoue K, Inoue S.
    Cancer Sci; 2020 Jul 28; 111(7):2440-2450. PubMed ID: 32437068
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.
    Shriver M, Stroka KM, Vitolo MI, Martin S, Huso DL, Konstantopoulos K, Kontrogianni-Konstantopoulos A.
    Oncogene; 2015 Aug 06; 34(32):4248-59. PubMed ID: 25381817
    [Abstract] [Full Text] [Related]

  • 12. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression.
    Zhang X, Zhou Y, Mao F, Lin Y, Shen S, Sun Q.
    Sci Rep; 2020 May 06; 10(1):7662. PubMed ID: 32376943
    [Abstract] [Full Text] [Related]

  • 13. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
    Li SY, Wang H, Mai HF, Li GF, Chen SJ, Li GS, Liang BC.
    Cancer Gene Ther; 2019 Nov 06; 26(11-12):374-387. PubMed ID: 30546116
    [Abstract] [Full Text] [Related]

  • 14. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R, Huang Z, Qian C, Wang M, Zheng Y, Jiang R, Yu C.
    Biochem Biophys Res Commun; 2020 Jun 11; 526(4):1005-1012. PubMed ID: 32307083
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. EPHA2 antisense RNA modulates EPHA2 mRNA levels in basal-like/triple-negative breast cancer cells.
    Okuyama T, Sakamoto R, Kumagai K, Nishizawa M, Kimura T, Sugie T, Kimura T.
    Biochimie; 2020 Dec 11; 179():169-180. PubMed ID: 33022313
    [Abstract] [Full Text] [Related]

  • 17. Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients' survival by downregulating miR-21.
    Gao J, Wang S, Zhang Z, Li J.
    BMC Cancer; 2021 Jun 28; 21(1):745. PubMed ID: 34182945
    [Abstract] [Full Text] [Related]

  • 18. LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis.
    Chen YL, Liu YN, Lin YT, Tsai MF, Wu SG, Chang TH, Hsu CL, Wu HD, Shih JY.
    J Biomed Sci; 2023 Sep 19; 30(1):80. PubMed ID: 37726723
    [Abstract] [Full Text] [Related]

  • 19. SP1-Induced Upregulation of LncRNA AFAP1-AS1 Promotes Tumor Progression in Triple-Negative Breast Cancer by Regulating mTOR Pathway.
    Li F, Xian D, Huang J, Nie L, Xie T, Sun Q, Zhang X, Zhou Y.
    Int J Mol Sci; 2023 Aug 29; 24(17):. PubMed ID: 37686205
    [Abstract] [Full Text] [Related]

  • 20. The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway.
    Cen S, Peng X, Deng J, Jin H, Deng Z, Lin X, Zhu DI, Jin M, Zhu Y, Zhang P, Luo Y, Huang H.
    Oncol Res; 2023 Aug 29; 31(3):375-388. PubMed ID: 37305386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.